146 related articles for article (PubMed ID: 38141127)
1. Prognostic and relapsing factors of primary autoimmune cerebellar ataxia: a prospective cohort study.
Liu M; Ren H; Wang L; Fan S; Bai L; Guan H
J Neurol; 2024 Mar; 271(3):1072-1079. PubMed ID: 38141127
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune Cerebellar Ataxia: Etiology and Clinical Characteristics of a Case Series from China.
Liu M; Ren H; Zhu Y; Fan S; Bai L; Wang J; Cui L; Guan H
Cerebellum; 2023 Jun; 22(3):379-385. PubMed ID: 35618871
[TBL] [Abstract][Full Text] [Related]
3. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.
Jones AL; Flanagan EP; Pittock SJ; Mandrekar JN; Eggers SD; Ahlskog JE; McKeon A
JAMA Neurol; 2015 Nov; 72(11):1304-12. PubMed ID: 26414229
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and outcome of patients with autoimmune cerebellar ataxia evaluated with the Scale for the Assessment and Rating of Ataxia.
Damato V; Papi C; Spagni G; Evoli A; Silvestri G; Masi G; Sabatelli E; Campetella L; McKeon A; Andreetta F; Riso V; Monte G; Luigetti M; Primiano G; Calabresi P; Iorio R
Eur J Neurol; 2022 Feb; 29(2):564-572. PubMed ID: 34710286
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapies for the Effective Treatment of Primary Autoimmune Cerebellar Ataxia: a Case Series.
Li J; Deng B; Song W; Li K; Ai J; Liu X; Zhang H; Zhang Y; Lin K; Shao G; Liu C; Zhang W; Chen X; Zhang Y
Cerebellum; 2023 Dec; 22(6):1216-1222. PubMed ID: 36434494
[TBL] [Abstract][Full Text] [Related]
6. Inositol 1,4,5-trisphosphate receptor type 1 autoantibody (ITPR1-IgG/anti-Sj)-associated autoimmune cerebellar ataxia, encephalitis and peripheral neuropathy: review of the literature.
Jarius S; Bräuninger S; Chung HY; Geis C; Haas J; Komorowski L; Wildemann B; Roth C
J Neuroinflammation; 2022 Jul; 19(1):196. PubMed ID: 35907972
[TBL] [Abstract][Full Text] [Related]
7. Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the United Kingdom.
Satukijchai C; Mariano R; Messina S; Sa M; Woodhall MR; Robertson NP; Ming L; Wassmer E; Kneen R; Huda S; Jacob A; Blain C; Halfpenny C; Hemingway C; O'Sullivan E; Hobart J; Fisniku LK; Martin R; Dopson R; Cooper SA; Williams V; Waters PJ; Ramdas S; Leite MI; Palace J
JAMA Netw Open; 2022 Jan; 5(1):e2142780. PubMed ID: 35006246
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Criteria for Primary Autoimmune Cerebellar Ataxia-Guidelines from an International Task Force on Immune-Mediated Cerebellar Ataxias.
Hadjivassiliou M; Graus F; Honnorat J; Jarius S; Titulaer M; Manto M; Hoggard N; Sarrigiannis P; Mitoma H
Cerebellum; 2020 Aug; 19(4):605-610. PubMed ID: 32328884
[TBL] [Abstract][Full Text] [Related]
9. Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy.
Ariño H; Gresa-Arribas N; Blanco Y; Martínez-Hernández E; Sabater L; Petit-Pedrol M; Rouco I; Bataller L; Dalmau JO; Saiz A; Graus F
JAMA Neurol; 2014 Aug; 71(8):1009-16. PubMed ID: 24934144
[TBL] [Abstract][Full Text] [Related]
10. Neurological Autoimmunity Associated With Homer-3 Antibody: A Case Series From China.
Liu M; Ren H; Fan S; Zhang W; Xu Y; Zhao W; Guan H;
Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34580182
[TBL] [Abstract][Full Text] [Related]
11. Peripheral nervous system involvement accompanies central nervous system involvement in anti-glial fibrillary acidic protein (GFAP) antibody-related disease.
Theuriet J; Cluse F; Gravier-Dumonceau A; Picard G; Closs S; Rogemond V; Timestit N; Bouhour F; Petiot P; Davy V; Chanson E; Arzalluz-Luque J; Marignier R; Honnorat J; Pegat A
J Neurol; 2023 Nov; 270(11):5545-5560. PubMed ID: 37540278
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies against eukaryotic translation elongation factor 1 delta in two patients with autoimmune cerebellar ataxia.
Guo L; Ren H; Fan S; Chao X; Liu M; Guan H; Wang J
Front Immunol; 2023; 14():1289175. PubMed ID: 38332912
[TBL] [Abstract][Full Text] [Related]
13. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
14. Autoimmunity as a prognostic factor in sporadic adult onset cerebellar ataxia.
Sivera R; Martín N; Boscá I; Sevilla T; Muelas N; Azorín I; Vílchez JJ; Bolonio M; Donat E; Ribes-Koninckx C; Bataller L
J Neurol; 2012 May; 259(5):851-4. PubMed ID: 21984193
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases.
Dubey D; Lennon VA; Gadoth A; Pittock SJ; Flanagan EP; Schmeling JE; McKeon A; Klein CJ
Neurology; 2018 Jan; 90(2):e103-e110. PubMed ID: 29222126
[TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis of relapsing anti-N-methyl-D-aspartate receptor encephalitis].
Hongzhi G; Weize K; Bin P; Yan H; Qiang L; Yuan J; Qing L; Hang S; Haitao R; Yicheng Z; Dawei S; Liying C
Zhonghua Yi Xue Za Zhi; 2015 Apr; 95(13):996-1001. PubMed ID: 26506710
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Novel Meningoencephalomyelitis.
Fang B; McKeon A; Hinson SR; Kryzer TJ; Pittock SJ; Aksamit AJ; Lennon VA
JAMA Neurol; 2016 Nov; 73(11):1297-1307. PubMed ID: 27618707
[TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics and prognosis of patients with anti-glutamic acid decarboxylase antibody-related cerebellar ataxia].
Bai L; Cai Y; Ren HT; Di WY; Liu MG; Fan SY; Guan HZ
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(25):1935-1937. PubMed ID: 35768393
[TBL] [Abstract][Full Text] [Related]
19. Predictive models in the diagnosis and treatment of autoimmune epilepsy.
Dubey D; Singh J; Britton JW; Pittock SJ; Flanagan EP; Lennon VA; Tillema JM; Wirrell E; Shin C; So E; Cascino GD; Wingerchuk DM; Hoerth MT; Shih JJ; Nickels KC; McKeon A
Epilepsia; 2017 Jul; 58(7):1181-1189. PubMed ID: 28555833
[TBL] [Abstract][Full Text] [Related]
20. Anti-neurochondrin antibody as a biomarker in primary autoimmune cerebellar ataxia-a case report and review of the literature.
Schwarzwald A; Salmen A; León Betancourt AX; Diem L; Hammer H; Radojewski P; Rebsamen M; Kamber N; Chan A; Hoepner R; Friedli C
Eur J Neurol; 2023 Apr; 30(4):1135-1147. PubMed ID: 36437687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
